Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Rectal Neoplasms 11Stomach Neoplasms 9Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Liver Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Osteosarcoma 4Cholangiocarcinoma 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Lung Neoplasms 3Locally Advanced Rectal Cancer 3Kidney Neoplasms 3Inflammatory Breast Neoplasms 3Turcot syndrome 2Sarcoma 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Etoposide 23Cisplatin 15Carboplatin 13Irinotecan 12apatinib 11anlotinib 10durvalumab 7Topotecan 6toripalimab 4surufatinib 4sintilimab 4atezolizumab 4Temozolomide 4Drug Therapy 4tislelizumab 3lobaplatin 3camrelizumab 3Simvastatin 3Radiotherapy 3Ifosfamide 3Albumin-Bound Paclitaxel 3pembrolizumab 2pegylated granulocyte colony-stimulating factor 2olaparib 2niraparib 2isophosphamide mustard 2avelumab 2X-Rays 2Platinum 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Small Cell Lung Carcinoma × Neoadjuvant Therapy × Clear all
NCT03523234 2018-09-05

Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage

Shanghai Pulmonary Hospital, Shanghai, China

Phase NA Unknown
300 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡